MiGenTra strives to establish equitable access to high-quality biologics at affordable prices for Egypt, the Middle East, and Africa (MEA) while simultaneously strengthening regional and local manufacturing capacities. The company thus contributes to the Global Health Initiative and efforts by the World Health Organization (WHO) and the International Finance Corporation (IFC) to address urgent, unmet medical needs.